The National Development and Reform Commission officially released the "13th Five-Year Plan for Biological Industry Development" (full text)

Recently, the National Development and Reform Commission has accelerated the promotion of the bio-industry into a national economy in accordance with the "Thirteenth Five-Year Plan for National Economic and Social Development of the People's Republic of China" and the "13th Five-Year National Strategic Emerging Industry Development Plan". The pillar industry has specially compiled the "13th Five-Year Plan for Biological Industry Development" and officially issued it. Among them, the current hot genetic testing, gene editing, cell therapy, immunotherapy and other fields have been mentioned. The "Planning" proposes in the development goal that the ability to achieve genetic testing covers more than 50% of the birth population. At the same time, by 2020, the scale of the bio-industry will reach 8-10 trillion yuan.

"13th Five-Year" Biological Industry Development Plan

The bio-industry is the most active and most influential emerging industry in the 21st century. It is the main direction of China's strategic emerging industries. It will seize the new round of scientific and technological revolution and the industrial revolutionary high point, accelerate the expansion of new industries, develop new economies, and foster new ones. Kinetic energy and building "healthy China" are of great significance. According to the "Thirteenth Five-Year Plan for National Economic and Social Development of the People's Republic of China" and the "13th Five-Year Plan for the Development of National Strategic Emerging Industries", in order to accelerate the promotion of the bio-industry as a pillar industry of the national economy, Planning, planning period is 2016-2020.

First, the status quo and the situation

Since the "Twelfth Five-Year Plan", with the rapid development of modern life sciences and the accelerated integration of biotechnology and information, materials, energy and other technologies, modern biotechnology breakthroughs and rapid industrialization of high-throughput sequencing, genome editing and bioinformatics analysis The bio-economy is accelerating to become a new economic form after the information economy, which has a profound impact on human production and life. New technologies such as targeted drugs, cell therapy, genetic testing, smart medical devices, wearable instant monitoring devices, telemedicine , and health big data are accelerating adoption. Smart medical and precision medical care are transforming traditional disease prevention, detection, and treatment. The model provides a new means for improving the health and quality of the people. The advancement of biological breeding technology has greatly promoted the improvement of the nutritional value of animals and plants, the enhancement of disease resistance and the increase of yield. The global GM crop planting area has accounted for 12% of the total arable land area, helping farmers to earn more than 150 billion US dollars, green Nutritional and functional animal and plant products are leading the way in food consumption. Bio-manufactured products are 30-50% more energy efficient than traditional petrochemical products, reducing environmental impact by 20-60%. Microorganisms and their components are increasingly being used to remove industrial waste and restore ecosystems. Biomass energy is becoming a boost. An important force in the energy production and consumption revolution, a green economy model based on carbon recycling is being established.

In recent years, developed economies such as the United States and Europe have focused on the bio-economy and further consolidate their leading position while promoting sustainable development. In the National Bioeconomic Blueprint, the US government clearly stated that “supporting research to lay the foundation for the 21st century bio-economy” is a priority for the science and technology budget. In the "Innovation for Sustainable Growth: European Bio-economy", the EU regards the bio-economy as a key element in implementing the European 2020 strategy and achieving smart development and green development. In the National Bio-Economic Policy Strategy, Germany proposed to achieve economic and social transformation, increase employment opportunities, and improve Germany's global competitiveness in the economic and scientific research fields by vigorously developing the bio-economy. Under the guidance of the US and European governments, the global capital market has increasingly favored the biological field, and the amount of venture capital, listing financing, and mergers and acquisitions has hit record highs. Relying on the advantages of scientific research institutions and talents in developed countries, a number of modern bio-industry clusters such as Boston Gene City and BioVale River Valley have become the source of innovation and development of the global bio-industry. In the face of fierce global competition, China should give full play to its resource advantages, market advantages, talent advantages and economic scale advantages, and strive to build a bio-economic powerhouse and seek a favorable position in the new round of global industrial competition.

Since the “Twelfth Five-Year Plan”, China's bio-industry compound growth rate has reached more than 15%. In 2015, the industrial scale exceeded 3.5 trillion yuan. In some areas, it is equivalent to developed countries and even has certain advantages. China's genetic testing service capability has been in a leading position in the world. Exported medicines have expanded from raw materials to higher-tech preparations. Artemisinin developed from traditional Chinese medicines has won the Nobel Prize in China's first natural science, high-end medical equipment. Breakthroughs in core technologies have dramatically reduced the prices of related products and services. The output of super rice has exceeded 1000 kilograms and reached the international advanced level. The total amount of bio-fermentation industry products ranks first in the world. Bioenergy replaces fossil energy in the year with more than 33 million tons of standard coal, which is among the highest in the world. A number of high-level and distinctive bio-industry clusters in the Beijing-Tianjin-Hebei, Yangtze River Delta, and Pearl River Delta regions have begun to take shape. China's bio-industry has a good foundation for accelerating development and achieving catch-up. At the same time, we must also clearly see that the achievements of China's bio-industry development can not meet the urgent needs of the people for health and ecology. The industrial ecosystem still has policy shortcomings that restrict the innovation and development of the industry, and pioneering and subversive technological innovation. Not much, China still has a long way to go to become a bio-economic power. We must further enhance the innovation capability of the bio-industry, deepen the reform of the industry regulation, continuously expand the new space for industrial application, meet the new needs of the people, and create new kinetic energy for economic growth.

Chinese Traditional Medicine Powder

Chinese Traditional Medicine Powder,Largehead Atractylodes Rhizome Extract,Traditional Medicinal Herbs,Atactylodis Macrocethalae Pe

Sichuan Aibang Weiye Biological Engineering Co., Ltd. , https://www.aibangpharm.com